Assessing dengue vaccination impact: Model challenges and future directions.
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few decades, the WHO has set out three specific key objectives in its disease control strategy: (i) to estimate the true burden of dengue by 2015; (ii) a reduction in dengue mortality by at least 50% by 20...
Main Authors: | Recker, M, Vannice, K, Hombach, J, Jit, M, Simmons, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Wilder-Smith, A, et al.
Published: (2018) -
Dengue serotype immune-interactions and their consequences for vaccine impact predictions
by: Lourenco, J, et al.
Published: (2016) -
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): A model comparison study
by: Flasche, S, et al.
Published: (2016) -
Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling
by: Beatty, M, et al.
Published: (2012) -
The effects of tertiary and quaternary infections on the epidemiology of dengue.
by: Wikramaratna, P, et al.
Published: (2010)